As part of the University at Buffalo, we are dedicated to high quality academic research, with a focus on translational use of quantitative neuroimaging metrics in neurological diseases and disorders like MS, Alzheimer’s, and stroke. We have published over 500 scholarly articles in peer-reviewed journals.
We provide cutting-edge quantitative outcome analytics for clinical and preclinical researchers and sponsors. We combine standards-based approaches with research expertise to deliver accurate, precise measures in compliance with regulatory oversight.
A key part of our mission at BNAC is to teach. We disseminate knowledge and train future neuroimagers, trained masters, and PhD students. We host fellowships for visiting doctors and research scholars. BNAC faculty have mentored and co-mentored hundreds of PhD students, MSc students, MD students, undergraduate students, neuroimaging fellows, and neurology residents.
Precise, advanced neuroimaging metrics to measure treatment effects while maximizing statistical power.
Full coordination with participating imaging centers from study initiation, individual site on-boarding, image acquisition, and analysis.
Strict adherence to the highest standards and regulatory requirements, including FDA/EMA, GCP, and ISO 9001:2015.
BNAC Researcher Niels Bergsland recently led a new study that indicates inflammation in the choroid plexus – a complex network of capillaries that produces cerebrospinal fluid in the brain – may affect disease progression and disability in people living with MS.
Robert Zivadinov, MD, Ph.D., has been named a SUNY Distinguished Professor – the highest faculty honor in the State University of New York (SUNY) system.
BNAC researchers develop a novel MRI technique that predicts staging of Paramagnetic Rim Lesions, a biomarker of chronic brain inflammation believed to be associated with progressive MS. They presented their work at ACTRIMS Forum 2023.
Groundbreaking BNAC study shows that keys to severe disability in multiple sclerosis are cortical, deep gray matter, and spinal cord damage rather than lesions.
Time Course of Lesion-induced Atrophy in Multiple Sclerosis.
-April 8, 2022
Cerebral Blood Flow Dependency on Systemic Arterial Circulation in Progressive Multiple Sclerosis.
-April 1, 2022
Functional Network Dynamics and Decreased Conscientiousness in Multiple Sclerosis.
-October 29, 2021
Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease.
-June 3, 2021
Director of IT and Neuroinformatics Development
BNAC Director
Director of Sequence Development
